Zura Financial Statements From 2010 to 2026

ZURA Stock   6.21  0.05  0.80%   
Zura Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zura Bio's valuation are provided below:
Market Capitalization
407 M
Earnings Share
(0.65)
We have found ninety-five available fundamental gauges for Zura Bio Limited, which can be analyzed and compared to other ratios and to its peers. All investors should make sure to confirm all of Zura Bio Limited prevalent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Zura Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zura Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.7 K, Other Operating Expenses of 40.2 M or Total Operating Expenses of 40.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.21. Zura financial statements analysis is a perfect complement when working with Zura Bio Valuation or Volatility modules.
  
Build AI portfolio with Zura Stock
Check out the analysis of Zura Bio Correlation against competitors.

Zura Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets117.2 M206.5 M135.1 M
Very volatile
Other Current Liabilities11.5 M21.6 M4.6 M
Slightly volatile
Total Current Liabilities15.1 M22.4 M5.6 M
Slightly volatile
Accounts Payable1.5 M843 K466.5 K
Slightly volatile
Cash213.1 M203 M41.3 M
Slightly volatile
Non Currrent Assets Other596.8 K628.2 K98.8 M
Slightly volatile
Cash And Short Term Investments213.1 M203 M41.3 M
Slightly volatile
Common Stock Shares Outstanding90.6 M86.3 M30 M
Slightly volatile
Liabilities And Stockholders Equity117.2 M206.5 M135.1 M
Very volatile
Other Current Assets2.7 M2.6 M815.4 K
Slightly volatile
Total Liabilities21.6 M22.4 M13.9 M
Slightly volatile
Total Current Assets215.8 M205.6 M42.2 M
Slightly volatile
Capital StockK6.3 K106.7 M
Slightly volatile
Common StockK6.3 K106.7 M
Slightly volatile
Short and Long Term Debt Total6.2 MM7.6 M
Slightly volatile
Deferred Long Term Liabilities2.8 M3.1 M3.4 M
Slightly volatile
Short and Long Term Debt284.5 K320 K349.3 K
Slightly volatile
Short Term Debt6.2 MM7.6 M
Slightly volatile

Zura Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization7.7 K8.1 K191.8 K
Slightly volatile
Other Operating Expenses40.2 M63.5 M15.4 M
Slightly volatile
Total Operating Expenses40.2 M63.5 M15.4 M
Slightly volatile
Net Interest Income9.7 M9.2 M1.7 M
Slightly volatile
Interest Income9.7 M9.2 M1.7 M
Slightly volatile
Selling General Administrative19.4 M35.4 M8.8 M
Slightly volatile
Research Development33.8 M28.1 M25.8 M
Slightly volatile
Cost Of Revenue7.2 K8.1 K8.8 K
Slightly volatile

Zura Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash48.7 M88.2 M19 M
Slightly volatile
Other Cashflows From Financing Activities59.3 M56.4 M11.3 M
Slightly volatile
Capital Expenditures64.1 K67.5 K1.2 M
Slightly volatile
Change To Account Receivables2.3 K2.6 K2.8 K
Slightly volatile
Total Cash From Financing Activities106.5 M126.3 M127.8 M
Slightly volatile
End Period Cash Flow213.1 M203 M41.3 M
Slightly volatile
Change To Netincome27.2 M20.6 M38.6 M
Slightly volatile
Change To Liabilities2.4 M4.7 M1.3 M
Slightly volatile
Stock Based Compensation9.8 M19.3 M3.5 M
Slightly volatile
Begin Period Cash Flow120.5 M114.8 M20.4 M
Slightly volatile
Issuance Of Capital Stock68.6 M69.9 M26.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation6.667.58.1859
Slightly volatile
Cash Per Share1.12.120.5405
Slightly volatile
Current Ratio8.668.244.8189
Slightly volatile
Capex Per Share0.00110.00110.0553
Slightly volatile
Interest Debt Per Share0.360.40.4414
Slightly volatile
Debt To Assets1.181.331.4482
Slightly volatile
Graham Number7.288.198.9419
Slightly volatile
Price Earnings To Growth Ratio0.05670.05780.0879
Slightly volatile
Quick Ratio8.668.244.8189
Slightly volatile
Net Income Per E B T0.780.90.9362
Pretty Stable
Cash Ratio8.558.143.6996
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.6334
Pretty Stable
Debt Ratio1.181.331.4482
Slightly volatile

Zura Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap132.6 M168.9 M147.2 M
Slightly volatile
Enterprise Value12.2 M12.9 M38.4 M
Slightly volatile

Zura Fundamental Market Drivers

Zura Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zura Bio Financial Statements

Zura Bio stakeholders use historical fundamental indicators, such as Zura Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zura Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zura Bio's assets and liabilities are reflected in the revenues and expenses on Zura Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zura Bio Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-320 K-336 K
Cost Of Revenue8.1 K7.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:
Check out the analysis of Zura Bio Correlation against competitors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. Anticipated expansion of Zura directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zura Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.65)
Return On Assets
(0.27)
Return On Equity
(0.45)
Understanding Zura Bio Limited requires distinguishing between market price and book value, where the latter reflects Zura's accounting equity. The concept of intrinsic value - what Zura Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zura Bio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zura Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.